Xeraya Capital invests in the life sciences globally, seeking significant minority equity positions in privately held companies.
By combining financial resources, industry expertise, and a global network, Xeraya Capital aims to accelerate the growth and success of its portfolio companies and contribute to advancements in healthcare and life sciences.
Early-stage and growth-stage companies.
Pharmaceuticals, biotechnology, medical devices, diagnostics, and healthcare services.
Xeraya Capital seeks out opportunities globally, with a particular focus on companies in Asia and North America.
Medical Technologies: We look to invest in companies that are developing game changing medical technologies related to the diagnosis, monitoring or treatment of medical conditions or to improve standards of care.
Pharmaceutical Biotech: Our investment interests include supporting companies in drug development from early stage platform technologies through to the more mature clinical stages. In addition, our focus also includes pharmaceutical technologies such as drug delivery and formulation.
Biorenewables & Others: We seek out innovative platforms that create value from waste materials, that reduce energy or resource consumption, and that lessen the environmental impact of energy and food production and transport. Our focus is on technology that displaces traditional industrial processes.